Delivery Order SPE2DB22D2005-SPE2DB24FJJM6
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of RYANODEX 250 MG VIALS. The contract, valued at $2,979.28, has a completion date of February 15, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of RYANODEX 250 MG VIALS. The $1,489.64 firm fixed-price contract has a completion date of June 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain to fulfill government contracts, particularly for the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 250 mg vials of the pharmaceutical product RYANODEX. The contract has a potential value of $7,448.20 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not designated as a set-aside contract. Amerisourcebergen Drug Corp also...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of RYANODEX 250 MG VIALS (4564821330) to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price delivery order, valued at $2,979.28, has an ultimate completion date of June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RYANODEX 250MG VIAL 1S, a pharmaceutical product, with a potential value of $14,896.40. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order contract is issued under a larger indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $9,632.64 firm fixed price delivery order is for RYANODEX 250 MG VIALS, a pharmaceutical product, with a performance period through July 15, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a potential value of $2,979.28 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger...
- This federal contract award, valued at $3,210.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product. The contract has a completion date of March 26, 2025 and utilizes a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RYANODEX 250 MG VIALS. The contract has a completion date of February 14, 2024 and a potential value of $2,979.28. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards to supply pharmaceuticals, medical supplies, and related distribution services in...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division (Vendor ID: TGxsdkVQRGhOYUpNR001SFhYREdNdz09) is for the supply of RYANODEX 250 MG VIALS (Contract ID: SPE2DB22D3011|SPE2DB24FQ1RR) to the Defense Logistics Agency (DLA), with a ceiling value of $7,448.20. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJJM6Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $7,448.20 by the Defense Logistics Agency (DLA) for the supply of RYANODEX 250 MG VIALS. The contract has a completion date of March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 3/4/24 |